Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Drug Discovery Today
|
March 19, 2013
Pharmacokinetics and the drug-target residence time concept
Göran Dahl, Tomas Akerud
Journal of Molecular Recognition : JMR
|
January 4, 2011
Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors
Matthis Geitmann, Göran Dahl, U Helena Danielson
Drug Discovery Today
|
April 12, 2016
A comprehensive company database analysis of biological assay variability
Christian Kramer, Göran Dahl, Christian Tyrchan, et al.
Biochemistry
|
October 21, 2009
Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors
Göran Dahl, Omar Gutiérrez Arenas, U Helena Danielson
The FEBS Journal
|
October 24, 2007
Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3
Göran Dahl, Anja Sandström, Eva Akerblom, et al.
Antiviral Therapy
|
August 24, 2007
Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3
Göran Dahl, Anja Sandström, Eva Akerblom, et al.
Bioorganic & Medicinal Chemistry
|
April 25, 2008
Beta-amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors
Johanna Nurbo, Shane D Peterson, Göran Dahl, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 22, 2021
The Vital Role of Proteomics in Characterizing Novel Protein Degraders
Andrew X Zhang, Katelyn Cassidy, Göran Dahl, et al.
Science Advances
|
August 9, 2019
Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain
Janna M Bigalke, Shintaro Aibara, Robert Roth, et al.
ACS Sensors
|
April 21, 2026
Proximity Binding Assay for PROTAC Ternary Complex Analysis
Irene Ponzo, Alice Soldà, Charlotte Crowe, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Drug Discovery Today
|
March 19, 2013
Pharmacokinetics and the drug-target residence time concept
Göran Dahl, Tomas Akerud
Journal of Molecular Recognition : JMR
|
January 4, 2011
Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors
Matthis Geitmann, Göran Dahl, U Helena Danielson
Drug Discovery Today
|
April 12, 2016
A comprehensive company database analysis of biological assay variability
Christian Kramer, Göran Dahl, Christian Tyrchan, et al.
Biochemistry
|
October 21, 2009
Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors
Göran Dahl, Omar Gutiérrez Arenas, U Helena Danielson
The FEBS Journal
|
October 24, 2007
Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3
Göran Dahl, Anja Sandström, Eva Akerblom, et al.
Antiviral Therapy
|
August 24, 2007
Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3
Göran Dahl, Anja Sandström, Eva Akerblom, et al.
Bioorganic & Medicinal Chemistry
|
April 25, 2008
Beta-amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors
Johanna Nurbo, Shane D Peterson, Göran Dahl, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 22, 2021
The Vital Role of Proteomics in Characterizing Novel Protein Degraders
Andrew X Zhang, Katelyn Cassidy, Göran Dahl, et al.
Science Advances
|
August 9, 2019
Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain
Janna M Bigalke, Shintaro Aibara, Robert Roth, et al.
ACS Sensors
|
April 21, 2026
Proximity Binding Assay for PROTAC Ternary Complex Analysis
Irene Ponzo, Alice Soldà, Charlotte Crowe, et al.
Page
of 3